title: Intracoronary Abciximab in Diabetic STEMI Patients: Questionable Benefit, Proven Harm.
authors: Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: j.p.henriques@amc.uva.nl.
authors: José P S
authors: JP
authors: Henriques
authors: Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
authors: Wouter J
authors: WJ
authors: Kikkert
mesh_terms: D000077284:Abciximab; D000911:Antibodies, Monoclonal; D003920:Diabetes Mellitus; D006801:Humans; D007140:Immunoglobulin Fab Fragments; D009203:Myocardial Infarction; D010975:Platelet Aggregation Inhibitors; D000072657:ST Elevation Myocardial Infarction; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab
keywords: STEMI; diabetes mellitus; myocardial infarction; myocardial revascularization